New research from CUNY identifies how brain immune cells drive neurodegeneration through stress-induced toxic lipid production, offering potential therapeutic targets.
New research suggests that reducing mandatory hand hygiene observations from 200 to 50 per unit monthly would maintain data quality while freeing resources for targeted infection prevention initiatives.
A European research initiative has made significant progress in identifying new treatments to protect heart muscle during acute cardiac events, with potential implications for both diabetic and non-diabetic patients.
UCLA Health study demonstrates significant impact of genetic diagnostics on treatment decisions and specialist referrals in complex neurodevelopmental cases, pointing towards more personalised medical approaches.
New research from the University of Nottingham demonstrates significant psychological and physiological impacts of digital technology intensity in modern workplaces, with implications for occupational health.
Early-onset colorectal cancer incidence rates are increasing in more than half of the countries studied worldwide, with the steepest rises seen in New Zealand, Chile, and Puerto Rico, according to comprehensive new research published in The Lancet Oncology [1].
A groundbreaking RNA-based technology allows therapeutic genes that are too large for conventional delivery methods to be successfully transported into cells, offering new hope for treating muscular dystrophies and other genetic disorders caused by mutations in large genes.
South Korean researchers have developed a soft, adhesive brain sensor that could significantly improve the effectiveness of ultrasound-based epilepsy treatments by enabling accurate, real-time monitoring of brain activity during stimulation.
Scientists have developed a revolutionary optical imaging technique that provides unprecedented views of blood vessels in the living brain, offering new ways to study neurological conditions like stroke and Alzheimer’s disease.
MIT and Novo Nordisk researchers have developed an ingestible capsule system that could enable oral delivery of medications typically requiring injection, such as insulin and therapeutic proteins. The needle-free device uses a biomimetic jet propulsion mechanism inspired by cephalopod physiology.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
Anna Flury
© Light: Science & Applications